Screener
Charles River Laboratories CRL Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Total assets | $7,532,145 | $7,135,422 |
| Liabilities, Redeemable Noncontrolling Interests and Equity | ||
| Current liabilities: | ||
| Accounts payable | $140,983 | $148,800 |
| Accrued compensation | 187,835 | 268,854 |
| Deferred revenue | 203,035 | 210,418 |
| Accrued liabilities | 380,101 | 270,085 |
| Other current liabilities | 222,792 | 222,158 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's accounts payable?
- Charles River Laboratories (CRL) reported accounts payable of $140.98M in Q2 2026.
- How has Charles River Laboratories's accounts payable changed year-over-year?
- Charles River Laboratories's accounts payable decreased by 3.3% year-over-year, from $145.8M to $140.98M.
- What is the long-term trend for Charles River Laboratories's accounts payable?
- Over 5 years (2020 to 2025), Charles River Laboratories's accounts payable has grown at a 4.0% compound annual growth rate (CAGR), from $122.48M to $148.8M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Charles River Laboratories's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude